Form C - Offering Statement:
SEC Accession No. 0001669191-24-000880
Filing Date
2024-08-21
Accepted
2024-08-21 09:34:36
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 10423
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 313328
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 1327364
4 CPA REVIEW REPORT reviewletter.pdf EX-99 330867
5 CERTIFICATE OF INCORPORATION certificateofincorporation.pdf EX-99 451182
6 CORPORATE BYLAWS corporatebylaws.pdf EX-99 617796
7 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 157305
8 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 244
  Complete submission text file 0001669191-24-000880.txt   4416834
Mailing Address 4200 MARATHON BLVD STE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BOULEVARD SUITE 200 AUSTIN TX 78756 760-783-3085
Aether Therapeutics Inc. (Filer) CIK: 0002004745 (see all company filings)

EIN.: 823723869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-34651 | Film No.: 241227520